Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Targeting Protein-Protein Interactions
Conferences  \  Discovery Chemistry Congress  \  Targeting Protein-Protein Interactions  \  Agenda  \  
RegisterLogin

's Biography


, ,

Dr. Nils Hansen is the CEO and founder of Vipergen ApS. He is the principal inventor of the enabling YoctoReactor® and Binder Trap Enrichment® drug discovery technology platforms. He previously worked for Praecis Pharmaceuticals Inc., (Waltham, MA, USA) and Symphogen A/S, (Copenhagen, Denmark). Dr. Hansen earned his Ph.D. in immunology from the University of Copenhagen, Denmark in 2000 and his M.Sc. in Chemistry and Biotechnology from the University of Aarhus, Denmark in 1996.

Image

Discovery of Small Molecule Inhibitors of Protein-protein Interactions Using DNA-encoded Chemical Libraries

Wednesday, 20 March 2013 at 16:15

Add to Calendar ▼2013-03-20 16:15:002013-03-20 17:15:00Europe/LondonDiscovery of Small Molecule Inhibitors of Protein-protein Interactions Using DNA-encoded Chemical LibrariesSELECTBIOenquiries@selectbiosciences.com

Discovery of small molecule inhibitors of protein-protein interactions from a 2 million compound DNA-encoded chemical library using a novel homogenous binding assay for the screening process.

Add to Calendar ▼2013-03-19 00:00:002013-03-20 00:00:00Europe/LondonTargeting Protein-Protein InteractionsSELECTBIOenquiries@selectbiosciences.com


Conference Sponsors